{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.1157","meta":{"versionId":"7","lastUpdated":"2022-03-02T18:02:37.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1157","version":"20211102","name":"Substance Use Disorder Short Acting Medication Administration","status":"active","date":"2022-03-03T18:46:01-05:00","publisher":"NCQA PHEMUR","compose":{"include":[{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1152"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1155"]}]},"expansion":{"identifier":"urn:uuid:e0fc3b9a-d078-4775-a99e-aed3a524d7d1","timestamp":"2022-06-10T12:17:50-04:00","total":7,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"310653000","display":"Drug addiction therapy using methadone (regime/therapy)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"G2067","display":"Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"G2068","display":"Medication assisted treatment, buprenorphine (oral); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"G2078","display":"Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"G2079","display":"Take-home supply of buprenorphine (oral); up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"H0020","display":"Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"H0033","display":"Oral medication administration, direct observation"}]}}